Latest Articles
- Research ArticleEffects of Vitamin D and Body Mass Index on Disease Risk and Relapse Hazard in Multiple SclerosisA Mendelian Randomization StudyMarijne Vandebergh, Bénédicte Dubois, An GorisApril 07, 2022
- Research ArticleTranscription Factor c-Maf Promotes Immunoregulation of Programmed Cell Death 1–Expressed CD8+ T Cells in Multiple SclerosisShusuke Koto, Norio Chihara, Ritsu Akatani, et al.April 05, 2022
- ArticleIncreased Remyelination and Proregenerative Microglia Under Siponimod Therapy in Mechanistic ModelsMichael Dietrich, Christina Hecker, Elodie Martin, et al.March 30, 2022
- ArticleNovel Cell-Based Assay for Alpha-3 Nicotinic Receptor Antibodies Detects Antibodies Exclusively in Autoimmune Autonomic GanglionopathyKaterina Karagiorgou, Maria Dandoulaki, Renato Mantegazza, et al.March 29, 2022
- Research ArticleMRI Characteristics of Autoimmune Encephalitis With Autoantibodies to GABAA ReceptorA Case SeriesBo Deng, Mengfei Cai, Yue Qiu, et al.March 25, 2022
- Research ArticleCryptococcal Meningitis Reported With Fingolimod TreatmentCase SeriesMaurizio Del Poeta, Brian J. Ward, Benjamin Greenberg, et al.March 22, 2022
- Research ArticleDiabetes Mellitus Is a Possible Risk Factor for Nodo-paranodopathy With Antiparanodal AutoantibodiesLuise Appeltshauser, Julia Messinger, Katharina Starz, et al.March 21, 2022
- Clinical/Scientific NoteCombined Central and Peripheral Demyelination With IgM Anti–Neurofascin 155 AntibodiesCase ReportAntoine Pegat, Emilien Delmont, Juliette Svahn, et al.March 21, 2022
- Research ArticleDynamics of Retinal Vessel Loss After Acute Optic Neuritis in Patients With Relapsing Multiple SclerosisLilian Aly, Christina Noll, Rebecca Wicklein, et al.March 17, 2022
- Research ArticleInfluence of Previous Disease-Modifying Drug Exposure on T-Lymphocyte Dynamic in Patients With Multiple Sclerosis Treated With OcrelizumabDoriana Landi, Alfonso Grimaldi, Francesca Bovis, et al.March 10, 2022
Pages
Advertisement
Dr. Daniel Friedman and Dr. Sharon Chiang